Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Development of novel sclerostin-resistant mouse model of T1D

Oct. 7, 2019

Liver-targeted uncouplers reverse type 2 diabetes, fatty liver in primates

Oct. 4, 2019

Free fatty acid receptor 4 agonists disclosed by Axxam

Oct. 4, 2019

Phase II data show efficacy of TTP-399 as an adjunctive therapy for type 1 diabetes

Oct. 3, 2019

Janssen presents free fatty acid FFA1 and/or FFA4 receptor agonists

Oct. 1, 2019

FDA approves Invokana for use in patients with type 2 diabetes and diabetic kidney disease

Oct. 1, 2019

FDA completes review of IND for mRNA-3927

Oct. 1, 2019

First patient dosed in phase IIb ICONA study of icosabutate

Sep. 27, 2019

Study reports new insight into, target for Krabbe disease

Sep. 27, 2019

DG-12P1 identified as first AI-discovered therapeutic candidate

Sep. 27, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...